177 related articles for article (PubMed ID: 15566926)
1. Effects of hormone replacement therapy or raloxifene on ambulatory blood pressure and arterial stiffness in treated hypertensive postmenopausal women.
da Costa LS; de Oliveira MA; Rubim VS; Wajngarten M; Aldrighi JM; Rosano GM; Neto CD; Gebara OC
Am J Cardiol; 2004 Dec; 94(11):1453-6. PubMed ID: 15566926
[TBL] [Abstract][Full Text] [Related]
2. Nondipping status does not attenuate the conjugated estrogen-induced improvement in aortic stiffness in postmenopausal women with untreated hypertension.
Tsioufis C; Tzioumis K; Dimitriadis K; Chatzis D; Skiadas I; Michailidis A; Toutouzas P; Kallikazaros I; Stefanadis C
Am J Hypertens; 2005 May; 18(5 Pt 1):607-11. PubMed ID: 15882542
[TBL] [Abstract][Full Text] [Related]
3. Effects of raloxifene on the renin-angiotensin-aldosterone system and blood pressure in hypertensive and normotensive osteoporotic postmenopausal women.
Sumino H; Ichikawa S; Kasama S; Takahashi T; Kumakura H; Takayama Y; Kanda T; Murakami M; Kurabayashi M
Geriatr Gerontol Int; 2010 Jan; 10(1):70-7. PubMed ID: 20102385
[TBL] [Abstract][Full Text] [Related]
4. Effects of raloxifene therapy on plasma renin and aldosterone levels and blood pressure in postmenopausal women.
Morgante G; Delia A; Musacchio MC; Severi FM; Petraglia F; De Leo V
Gynecol Endocrinol; 2006 Jul; 22(7):376-80. PubMed ID: 16864147
[TBL] [Abstract][Full Text] [Related]
5. Predictors of hot flushes in postmenopausal women who receive raloxifene therapy.
Aldrighi JM; Quail DC; Levy-Frebault J; Aguas F; Kosian K; Garrido L; Bosio-Le Goux B; Saráchaga M; Graebe A; Niño AJ; Nickelsen T
Am J Obstet Gynecol; 2004 Dec; 191(6):1979-88. PubMed ID: 15592280
[TBL] [Abstract][Full Text] [Related]
6. Effects of estrogen, raloxifene, and hormone replacement therapy on serum C-reactive protein and homocysteine levels.
Gol M; Akan P; Dogan E; Karas C; Saygili U; Posaci C
Maturitas; 2006 Feb; 53(3):252-9. PubMed ID: 15990257
[TBL] [Abstract][Full Text] [Related]
7. Effect of raloxifene and hormone therapy on serum markers of brain and whole-body cholesterol metabolism in postmenopausal women.
Vogelvang TE; Mijatovic V; van der Mooren MJ; Pinsdorf U; von Bergmann K; Netelenbos JC; Lütjohann D
Maturitas; 2005 Apr; 50(4):312-20. PubMed ID: 15780532
[TBL] [Abstract][Full Text] [Related]
8. Effects of estradiol alone and combined with norethisterone acetate on pulse-wave velocity in hypertensive postmenopausal women.
Arruda CG; Aldrighi JM; Bortolotto LA; Alecrin IN; Ramires JA
Gynecol Endocrinol; 2006 Oct; 22(10):557-63. PubMed ID: 17135035
[TBL] [Abstract][Full Text] [Related]
9. Effects of amlodipine and valsartan on vascular damage and ambulatory blood pressure in untreated hypertensive patients.
Ichihara A; Kaneshiro Y; Takemitsu T; Sakoda M
J Hum Hypertens; 2006 Oct; 20(10):787-94. PubMed ID: 16810279
[TBL] [Abstract][Full Text] [Related]
10. Blood pressure effects of the oral contraceptive and postmenopausal hormone therapies.
Boldo A; White WB
Endocrinol Metab Clin North Am; 2011 Jun; 40(2):419-32, ix. PubMed ID: 21565676
[TBL] [Abstract][Full Text] [Related]
11. The effect of hormone replacement therapy on arterial blood pressure and vascular compliance in postmenopausal women with arterial hypertension.
Kawecka-Jaszcz K; Czarnecka D; Olszanecka A; Rajzer M; Jankowski P
J Hum Hypertens; 2002 Jul; 16(7):509-16. PubMed ID: 12080436
[TBL] [Abstract][Full Text] [Related]
12. Raloxifene, soy phytoestrogens and endothelial function in postmenopausal women.
Katz DL; Evans MA; Njike VY; Hoxley ML; Nawaz H; Comerford BP; Sarrel PM
Climacteric; 2007 Dec; 10(6):500-7. PubMed ID: 18049943
[TBL] [Abstract][Full Text] [Related]
13. Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.
Christodoulakos G; Lambrinoudaki I; Panoulis C; Sioulas V; Rizos D; Caramalis G; Botsis D; Creatsas G
Maturitas; 2005 Apr; 50(4):321-30. PubMed ID: 15780533
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular effects of raloxifene: the arterial and venous systems.
Blumenthal RS; Baranowski B; Dowsett SA
Am Heart J; 2004 May; 147(5):783-9. PubMed ID: 15131531
[TBL] [Abstract][Full Text] [Related]
15. Can estrogen or selective estrogen-receptor modulators preserve cognitive function in elderly women?
Mayeux R
N Engl J Med; 2001 Apr; 344(16):1242-4. PubMed ID: 11309641
[No Abstract] [Full Text] [Related]
16. Effect of raloxifene on the vaginal epithelium of postmenopausal women.
Delmanto A; Nahas-Neto J; Nahas EA; de Oliveira ML; Fernandes CE; Traiman P
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):187-92. PubMed ID: 18400357
[TBL] [Abstract][Full Text] [Related]
17. Effects of estrogens and selective estrogen receptor modulators on indicators of cardiovascular health in postmenopausal women.
Klein KP; Herrington DM
Medscape Womens Health; 2002; 7(5):2. PubMed ID: 12466731
[No Abstract] [Full Text] [Related]
18. Modulation of vascular tone control under isometric muscular stress: role of estrogen receptors.
Ciccone MM; Scicchitano P; Cortese F; Gesualdo M; Zito A; Tesorio M; Guida P; Papagni A; Federici A; Cicinelli E
Vascul Pharmacol; 2013 Jan; 58(1-2):127-33. PubMed ID: 23070057
[TBL] [Abstract][Full Text] [Related]
19. Effects of conjugated equine estrogens or raloxifene on lipid profile, coagulation and fibrinolysis factors in postmenopausal women.
Dias AR; Melo RN; Gebara OC; D'Amico EA; Nussbacher A; Halbe HW; Pinotti JA
Climacteric; 2005 Mar; 8(1):63-70. PubMed ID: 15804733
[TBL] [Abstract][Full Text] [Related]
20. Raloxifene.
Gass ML
South Med J; 1999 Nov; 92(11):1120-3. PubMed ID: 10586846
[No Abstract] [Full Text] [Related]
[Next] [New Search]
